Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Please Note: The journal will be closed for new submissions from Mon Jun 15th 2026 for approximately 2 months to enable us to catch up with a backlog due to record numbers in recent months.

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

NB:

  • The journal does not accept case reports
  • From 6 April 2026 APCs will apply to manuscripts submitted from countries classified as upper-middle-income or high-income.
  • Manuscripts may be declined after 60 days if suitable reviewers cannot be secured, to minimise delays and allow authors to submit their work elsewhere.
Articles
Editorials
Special issues
Author interviews
1729-characteristics-of-relapsed-and-refractory-paediatric-hodgkin-lymphoma-a-10-year-retrospective-study-of-an-lmic
Quratulain Riaz, Rabel Gul, Vashma Junaid, Wasfa Farooq, Naema Khayyam
1708-subcutaneous-versus-intravenous-administration-of-trastuzumab-a-minimization-cost-analysis-with-real-world-data-from-a-reference-cancer-centre-in-peru
Iris Otoya, Natalia Valdiviezo, Katia Roque, Zaida Morante, Tatiana Vidaurre, Silvia P. Neciosup, Mónica J. Calderón, Henry L. Gomez
1674-clinical-characteristics-outcomes-and-prognostic-factors-in-kras-mutant-lung-cancers-experience-from-a-tertiary-care-cancer-center-in-india
Vanita Noronha, Laboni Sarkar, Vijay Patil, Nandini Menon, Minit Shah, Akash Pawar, Oindrila Roy Chowdhury, Omshree Shetty, Anuradha Chougule, Pratik Chandrani, Rajiv Kaushal, Trupti Pai, Amit Janu, Nivedita Chakrabarty, Kumar Prabhash
1644-re-challenge-of-immune-checkpoint-inhibitor-pembrolizumab-with-concurrent-tocilizumab-after-prior-grade-3-pneumonitis
Chitrakshi Nagpal, Sameer Rastogi, Shamim A Shamim, Sneha Prakash
1643-successful-long-term-management-of-metastatic-clear-cell-renal-cell-carcinoma-with-nivolumab-a-case-report-and-literature-review
Nicolás Duque Clavijo, Paula A Lara, John Alejandro Murillo Silva, Iván Camilo Triana, Henry Alexander Vargas, Luis Eduardo Pino, Javier Mauricio Segovia, Erick Andrés Cantor
1569-epcam-expression-negatively-regulates-e-cadherin-function-in-colorectal-carcinomas
Uchenna Simon Ezenkwa, Gabriel Olabiyi Ogun, Mbwas Isaac Mashor, Olufemi John Ogunbiyi
1556-myeloid-derived-suppressor-cells-mdscs-what-do-we-currently-know-about-the-effect-they-have-against-anti-pd-1-pd-l1-therapies
Ronald Sergio Limón Tellez, Lucia Reynolds, Miguel A Piris
1500-real-world-analysis-of-the-use-of-lenvatinib-in-differentiated-thyroid-cancers
Zoya Peelay, Deevyashali Parekh, Vijay M Patil, Vanita Noronha, Nandini Menon, Kumar Prabhash
1489-targeting-braf-v600e-in-metastatic-colorectal-cancer-where-are-we-today
Rodrigo Motta Guerrero, Veronica Arnao Labajos, Sophia Lozano Ballena, Carlos Aliaga Macha, Miguel Sotelo Lezama, Cristian Pacheco Roman, Paola Montenegro Beltran, Alejandro Figueroa Torrejon
1464-retrospective-analysis-checkpoint-inhibitor-accessibility-for-thoracic-and-head-and-neck-cancers-and-factors-influencing-it-in-a-tertiary-centre-in-india
Vijay Patil, George Abraham, Madala Ravikrishna, Atanu Bhattacharjee, Vanita Noronha, Deevyashali Parekh, Nandini Menon, Jyoti Bajpai, Kumar Prabhash

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation